Log In
Print
BCIQ
Print
Print this Print this
 

EZH2 inhibitors

  Manage Alerts
Collapse Summary General Information
Company Constellation Pharmaceuticals Inc.
DescriptionEnhancer of zeste homolog 2 (EZH2) inhibitor
Molecular Target Enhancer of zeste homolog 2 (EZH2)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentDiscovery
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today